Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
A. N. Honko, R. Hunegnaw, J. I. Moliva, A. Ploquin, C. N. M. Dulan, T. Murray, D. Carr, K. E. Foulds, J. B. Geisbert, T. W. Geisbert, J. C. Johnson, S. E. Wollen-Roberts, J. C. Trefry, D. A. Stanley, N. J. Sullivan
A single dose of ChAd3-SUDV vaccine protected macaques from lethal SUDV challenge via parenteral and aerosol routes.
bioRxiv · Feb 7, 2024 · PreprintImmunology
C. A. Freas, A. Narendra, T. Murray, K. Cheng
This study shows nocturnal bull ants use polarized moonlight for navigation during the night, similar to how they use solar polarized light during the day.
bioRxiv · Dec 28, 2023Animal Behavior & Cognition
D. Mai, A. Jahn, T. Murray, M. Morikubo, P. N. Lim, M. M. Cervantes, L. K. Pham, J. C. Nemeth, K. B. Urdahl, A. H. Diercks, A. Aderem, A. C. Rothchild
This study shows that prior exposure to mycobacteria remodels alveolar macrophages, enhancing their pro-inflammatory response to Mtb infection through both intrinsic changes and environmental factors.
bioRxiv · Sep 19, 2022Immunology
R. Hunegnaw, A. Honko, L. Wang, D. Carr, T. Murray, W. Shi, C. N. M. Dullan, K. E. Foulds, K. N. Agans, R. W. Cross, J. B. Geisbert, T. W. Geisbert, C. Cheng, A. Ploquin, D. A. Stanley, , N. J. Sullivan
A single-shot ChAd3-MARV vaccine provided rapid and durable protection against lethal Marburg virus infection in macaques, with antigen-specific antibodies correlating strongly with immunity.
bioRxiv · Dec 22, 2021 · PreprintImmunology
A. Thomas, K.-H. Song, A. Upadhyay, V. Papadopoulou, D. Ramirez, R. Beninger, M. Lowerison, P. Song, T. Murray, M. A. Borden
This study uses biomimetic lung surfactant to stabilize microbubbles created from nanodrops for improved ultrasound imaging.
bioRxiv · Nov 3, 2020Bioengineering
V. Quaranta, C. Rainer, S. R. Nielsen, M. Raymant, M. S. Ahmed, D. Engle, A. Taylor, T. Murray, F. Campbell, D. Palmer, D. Tuveson, A. Mielgo, M. Schmid
This study shows that macrophage-derived granulin promotes resistance to immune checkpoint inhibitors in metastatic pancreatic cancer by excluding CD8+ T cells, and blocking granulin improves anti-tumor immunity.
bioRxiv · Dec 15, 2017Cancer Biology